Biotech News

New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

Progyny (PGNY)ProgynyCompany update

More than 70% of members in the study reported symptom improvement, with the greatest gains among those receiving both personalized coaching and menopause-trained provider care NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family

Related news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

Stock data

Close
34.37 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States